Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
GSK
GSK
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
GSK News
GSK's Wellcovorin Approved by FDA for Cerebral Folate Deficiency
5h ago
seekingalpha
FDA Approves Expanded Use of Wellcovorin for Cerebral Folate Deficiency
2h ago
Benzinga
GSK and Alfasigma Enter License Agreement for Linerixibat
1d ago
NASDAQ.COM
Trump's Comments Lead to Drop in Tylenol Prescriptions for Pregnant Women
4d ago
seekingalpha
CDC Urges Vaccination Amid Measles Outbreak
Mar 03 2026
seekingalpha
Funko Shares Surge 25% as Investor Urges Strategic Alternatives
Feb 27 2026
Benzinga
ViiV's VH184 Phase 1 Data Shows Promising Long-Acting Potential
Feb 25 2026
seekingalpha
GSK Acquires 35Pharma for $950 Million
Feb 25 2026
Benzinga
GSK Acquires 35Pharma for $950 Million
Feb 25 2026
seekingalpha
Overview of FDA Regulatory Developments
Feb 25 2026
NASDAQ.COM
GSK Acquires 35Pharma for $950 Million
Feb 25 2026
NASDAQ.COM
Frontier Biotechnologies Signs $1B Licensing Deal with GSK
Feb 24 2026
seekingalpha
Bora Pharmaceuticals Renews Five-Year Partnership with GSK
Feb 24 2026
NASDAQ.COM
Bora Renews Five-Year Strategic Partnership with GSK
Feb 23 2026
Newsfilter
Epstein Files Trigger Political Crisis Across Europe
Feb 19 2026
Benzinga
Merck Reports Positive Results from RSV Trial
Feb 19 2026
Benzinga
Show More News